Indivior’s once-monthly schizophrenia injection gets US green lightRegulators authorities in the US have approved Indivior’s long-acting injectable treatment for adults with schizophrenia. Perseris (risperidone) won Share XIndivior’s once-monthly schizophrenia injection gets US green lighthttps://pharmaphorum.com/news/indivior-schizophrenia-perseris-fda/